Thus, it is plausible that the impact of DHA on macrophage related to NAFLD/NASH pathogenesis can be explained by the fact that DHA simultaneously limits cell access to BTC and TLR2/4 agonists. Here, TLR2 is linked to metabolic dysfunction-associated steatotic liver disease.